Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Terazosin-d8 | 1006718-20-2 | 99.2% | 1 MG
Supplier: Medchemexpress LLC HYB0371S1MG
Terazosin-d8 is a deuterium labeled version of Terazosin, a quinazoline derivative and a competitive, orally active α1-adrenoceptor antagonist. It functions by relaxing blood vessels and opening the bladder, showing potential for treating benign prostatic hyperplasia (BPH) and high blood pressure. Deuteration can affect the pharmacokinetic and metabolic profiles of drugs.
- Used as a tracer
- Functions as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Competitive and orally active α1-adrenoceptor antagonist
- Relaxing blood vessels and opening the bladder
- Potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?